N-(3-Methoxybenzyl)Palmitamide

• UNSPSC Description:

  N-(3-Methoxybenzyl)Palmitamide is a promising inhibitor of FAAH for the treatment of pain, inflammation and CNS degenerative disorders[1].

• Target Antigen:

  FAAH

• Type:

  Natural Products

• Related Pathways:

  Metabolic Enzyme/Protease;Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/n-3-methoxybenzyl-palmitamide.html

• Purity:

  99.96

• Solubility:

  DMSO : 12.5 mg/mL (ultrasonic)

• Smiles:

  CCCCCCCCCCCCCCCC(NCC1=CC=CC(OC)=C1)=O

• Molecular Weight:

  375.59

• References & Citations:

  [1]Mariam Alamoudi, et al. Inhibitory effect of macamides: N-benzylpalmitamide and N-(3-methoxybenzyl)palmitamide on fatty acid amide hydrolase (FAAH). FASEB J.  1 Apr 2015.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture and light)

• Clinical Information:

  No Development Reported

• CAS Number:

  847361-96-0